Compassus Taps Growth Veteran to Navigate Home Care Boom

BRENTWOOD, Tenn. – March 17, 2026 – In a move signaling aggressive expansion plans, national home-based care provider Compassus has appointed Chris Core, a seasoned healthcare executive with a formidable track record in scaling complex organizations, as its new Chief Growth Officer. The appointment comes as the demand for home health, hospice, and palliative care skyrockets, positioning Compassus to solidify its leadership in a rapidly evolving market.

Core is tasked with spearheading the company's enterprise growth strategy and commercial execution. His arrival is a clear statement of intent from Compassus to not only capture a larger share of the burgeoning home-based care sector but to do so by expanding access to its integrated care model across the nation.

A Proven Architect of Growth

Chris Core brings over 25 years of leadership experience spanning the biopharmaceutical, physician services, and retail health sectors. His most recent and notable success was as a founding executive team member and Chief Growth Officer at Lumexa Imaging, formerly known as US Radiology Specialists. During his tenure, he was instrumental in the strategies that saw the outpatient imaging platform explode from just 20 centers to more than 180 nationwide, a nine-fold increase that showcases his ability to execute large-scale growth.

This experience in rapid, strategic expansion is precisely what Compassus leadership sought. "Chris brings a rare combination of strategic vision, operational discipline and deep health care experience," said Mike Asselta, CEO of Compassus, in the company's announcement. "His ability to scale commercial organizations thoughtfully and build strong partnerships aligns directly with our growth strategy and our commitment to delivering care that is both high quality and deeply person-centered."

Core’s extensive resume also includes senior leadership roles at specialty biopharmaceutical firms Bio Products Laboratory and Grifols, where he managed commercial strategy for complex therapies. His foundational career years at industry giants GlaxoSmithKline and Lilly provided him with deep expertise in go-to-market execution, a critical skill for navigating the competitive healthcare landscape.

Navigating the Home Care Boom

Core’s appointment is strategically timed. The home-based care market is experiencing unprecedented growth, transforming from a niche service to a cornerstone of the modern healthcare system. Driven by an aging population, the rising prevalence of chronic diseases, and a strong patient preference for receiving care at home, the market is on a steep upward trajectory. Global market projections estimate the home healthcare sector could surpass $1 trillion by 2034, with related fields like home infusion and palliative care also seeing double-digit growth rates.

However, this boom is not without its challenges. The industry is grappling with severe staffing shortages, with some reports indicating that up to 95% of providers face moderate to severe labor constraints. Furthermore, navigating complex reimbursement structures and intense competitive pressure requires sophisticated operational and strategic planning. Core's role will be to steer Compassus through these turbulent waters, leveraging growth opportunities while mitigating the inherent risks of a strained system.

An Engine for Integrated, Sustainable Scale

At the heart of the company’s strategy is a dual focus on an integrated care model and a specialized Management Services Organization (MSO) approach. This structure is designed to deliver both high-quality patient care and sustainable business growth, and it is the engine Core will now help supercharge.

Compassus provides a full continuum of services—including home health, home infusion, palliative care, and hospice—under one umbrella. This integrated model aims to provide seamless, coordinated care for patients with advanced illnesses, reducing costly hospital readmissions and improving quality of life. The company's "Care for who I am" culture reflects this patient-centric philosophy, focusing on individual needs beyond clinical diagnoses.

Supporting this clinical mission is the MSO, a robust back-end platform that provides the clinical, operational, and administrative infrastructure needed for efficient scaling. This MSO enables Compassus to form strategic joint ventures with major health systems, such as Ascension and Bon Secours Mercy Health, expanding its footprint while allowing partners to offer high-quality home-based care without building the infrastructure from scratch. By employing proprietary analytics and value-based models, the MSO aligns financial incentives with patient outcomes, a key differentiator in the shift away from fee-for-service healthcare.

"It's deeply rewarding to join an organization that approaches growth with intention and puts patients, families and providers at the center of every decision," Core stated. "I've seen firsthand the powerful outcomes that are generated when you help patients find the right care, at the right time, and at the right site of service."

As Core takes the helm of Compassus's growth initiatives, his mission is clear: to leverage his extensive experience to expand the reach of a care model that is increasingly vital. His success will be measured not just in new markets and partnerships, but in the number of patients who gain access to integrated, person-centered care in the comfort of their own homes.